Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.72 Analyst target: $14.89 Upside: 765.70%
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.